# clm_55D207F88E40

subject: AbbVie (/record/abbvie.md)  
predicate: total_equity  
value: 16,283,000,000 United States dollar  
valid_from: 2022-03-31  
valid_to: 2022-06-30  
published: 2022-05-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_3DA39727C116  
last_updated: 2026-11-08  
cite: AsOf. "AbbVie total equity: 16,283,000,000 United States dollar", as of 2022-03-31 (until 2022-06-30). Claim clm_55D207F88E40, https://asof.is/claim/clm_55D207F88E40, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2022, filed 2022-05-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm (primary, SEC EDGAR 10-Q Q1 FY2022, published 2022-05-06)

## Supersedes

- [AbbVie](/record/abbvie.md) | total_equity | 15,408,000,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_55D207F88E40](/claim/clm_55D207F88E40.md) | [clm_B2E8F0E008D0](/claim/clm_B2E8F0E008D0.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.